MediLink Therapeutics
PrivateLast Round
Series B
Mar 14, 2022
Total Funding Raised
$120M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MediLink Therapeutics is a biopharmaceutical company that develops innovative antibody-drug conjugates (ADC) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MediLink Therapeutics Comparables
Compare MediLink Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duality Biotherapeutics Inc | 93% | |
| Aimed Bio Inc. | 82% | |
| LigaChem Biosciences | 79% |
MediLink Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 14, 2022 | ||||
| Series A | Mar 1, 2021 |
MediLink Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| Loyal Valley Capital | Series B, Series A |
| Highlight Capital | Series B |
| LYFE Capital | Series B |
| Legend Capital | Series B |
| Qiming Venture Partners | Series B, Series A |
| Panacea Venture Healthcare | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 76% MoM.
- Jul 1, 2025
Dr. Weichang Zhou appointed as new CTO.
Recent news
Latest coverage and updates
- is_developingJul 15, 2026
Medilinkthera is developing antibody-drug conjugate YL201 on Jul 15th '26.
MediLink Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MediLink Therapeutics's valuation, stock price, and market status.
Is MediLink a public or private company?
MediLink is a private company.
What is the current stock price of MediLink?
MediLink is a private company with no public stock price. No recent secondary market data is available.
How much is MediLink worth (valuation)?
Valuation information for MediLink is not publicly available.
Can I buy MediLink stock?
MediLink shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MediLink's last funding round?
MediLink's most recent funding round was Series B on March 14, 2022.
Who are the main investors in MediLink?
Key investors in MediLink include Loyal Valley Capital, LYFE Capital, Qiming Venture Partners, Apricot Capital.
Will MediLink IPO soon?
No public IPO plans have been announced for MediLink.
How can I track MediLink secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MediLink's secondary market activity and sign up for updates.